News

23 juin 2021

Clinical trial: FRAXA-Funded Clinical Trial of PDE4D Inhibitor

Fragile X syndrome and phosphodiesterases Fragile X syndrome (FXS) is the most common form of inherited intellectual disability. It is a rare genetic neurodevelopmental disorder characterised […]
17 mai 2021

Down syndrome: a molecule that targets cognitive impairments enters the decisive phase of clinical trials

Significant headway has been made in recent years to understand the causes of intellectual disability in people with Down syndrome, but therapeutic research on this syndrome […]